Tech Company Financing Transactions

Enable Injections Funding Round

Enable Injections closed a $215 million Series C funding round on 2/4/2022. Investors included Magnetar Capital Return, Cincinnati Children's Hospital Medical Center and CincyTech.

Transaction Overview

Company Name
Announced On
2/4/2022
Transaction Type
Venture Equity
Amount
$215,000,000
Round
Series C
Proceeds Purpose
This financing will provide additional resources to onboard important new pharma partner programs and accelerate our commercialization programs and platforms with existing pharma partners.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
2863 East Sharon Rd.
Cincinnati, OH 45241
USA
Email Address
Overview
Enable Injections develops and manufactures devices that allow patient self-administration of high volume/viscosity drugs. The Enable Injector technology is a discrete body-worn device that provides a comfortable injection experience allowing the patient to continue with normal daily activities.
Profile
Enable Injections LinkedIn Company Profile
Social Media
Enable Injections Company Twitter Account
Company News
Enable Injections News
Facebook
Enable Injections on Facebook
YouTube
Enable Injections on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Michael Hooven
  Michael Hooven LinkedIn Profile  Michael Hooven Twitter Account  Michael Hooven News  Michael Hooven on Facebook
Chief Financial Officer
Timothy Flaherty
  Timothy Flaherty LinkedIn Profile  Timothy Flaherty Twitter Account  Timothy Flaherty News  Timothy Flaherty on Facebook
VP - Administration
Susan Spies
  Susan Spies LinkedIn Profile  Susan Spies Twitter Account  Susan Spies News  Susan Spies on Facebook
VP - Manufacturing
John Love
  John Love LinkedIn Profile  John Love Twitter Account  John Love News  John Love on Facebook
VP - Operations
Eileen Rogers
  Eileen Rogers LinkedIn Profile  Eileen Rogers Twitter Account  Eileen Rogers News  Eileen Rogers on Facebook
VP - R & D
Matthew Huddleston
  Matthew Huddleston LinkedIn Profile  Matthew Huddleston Twitter Account  Matthew Huddleston News  Matthew Huddleston on Facebook
VP - Regulatory Affairs
Dominick Villani
  Dominick Villani LinkedIn Profile  Dominick Villani Twitter Account  Dominick Villani News  Dominick Villani on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/4/2022: Snapfix venture capital transaction
Next: 2/4/2022: Tuum venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary